← SynDRA
FN-1501
SynDRA canonical compound SYN1969987 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | CDk2 | CDK4 | CDK6 | FLT3 |
| Mechanism of action | tyrosine kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- tyrosine kinase inhibitor
Cross-references
Synonyms
- CHEMBL4077071
- UNII-6MC966B505
- TQR1001
- BDBM50270304
- NSC781143
- 6MC966B505
- NSC-781143
- HY-111361
- CS-0039834
- 4((7HPyrrolo[2,3d]pyrimidin-4-yl)amino)N(4-((4-methylpiperazin-1-yl)methyl)phenyl)1Hpyrazole-3-carboxamide
- 4-((7H-Pyrrolo (2,3-d)pyrimidin-4-yl)amino)-N-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrazole-3-carboxamide
- 4-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrazole-5-carboxamide
- 4a?(7Ha'Pyrrolo[2,3a'd]pyrimidin-4-yl)amino)a'Na?4-((4-methylpiperazin-1-yl)methyl)phenyl)a?Ha'pyrazole-3-carboxamide
- N-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-4-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1H-pyrazole-5-carboxamide
Look up FN-1501 in the interactive SynDRA portal →